Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing NaN - NaN of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 31, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +7 more
  • WM-A1-3389
  • Pembrolizumab
  • Seoul, Seocho-gu, Korea, Republic of
  • +1 more
May 14, 2023

Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin, Docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +212 more
Jan 26, 2023

Non Small Cell Lung Cancer Trial in Worldwide (Taletrectinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Beverly Hills, California
  • +58 more
Dec 13, 2022

Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Squamous Non-small-cell Lung Cancer Trial in Worldwide

Recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • Dhaka, Bangladesh
  • +139 more
Dec 8, 2022

Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +43 more
Nov 25, 2022

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Orange, California
  • +13 more
Nov 7, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Amivantamab, Lazertinib, Zirabev)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Angers, France
  • +30 more
Oct 31, 2022

Non Small Cell Lung Cancer, Urothelial Cancer, Renal Cell Carcinoma Trial in Worldwide (INCB086550)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Burgas, Bulgaria
  • +19 more
Oct 20, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Telisotuzumab Vedotin)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Telisotuzumab Vedotin
  • Clayton, Victoria, Australia
  • +54 more
Aug 23, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

Non Small Cell Lung Cancer Trial in Seoul (Neoadjuvant lazertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Neoadjuvant lazertinib
  • Seoul, Korea, Republic of
    Konkuk University Medical Center
Jul 20, 2022

Non Small Cell Lung Cancer Trial in Seoul (sotorasib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 5, 2022

Non Small Cell Lung Cancer Trial in France, Korea, Republic of, Spain (Fexofenadine tablet dosing, Osimertininb tablet dosing)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Fexofenadine tablet dosing
  • Osimertininb tablet dosing
  • Rennes Cedex 9, France
  • +6 more
Jul 4, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Nivolumab
  • +8 more
  • Glendale, Arizona
  • +135 more
Feb 28, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Irvine, California
  • +15 more
Mar 9, 2022

Non Small Cell Lung Cancer Trial in Seoul (durvalumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Feb 9, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • Necitumumab
  • +2 more
  • Chandler, Arizona
  • +181 more
Feb 4, 2022

Non Small Cell Lung Cancer Trial in Seoul (Lazertinib , a combination group of SBRT, Lazertinib single administration group)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Lazertinib , a combination group of SBRT
  • Lazertinib single administration group
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 20, 2021

Non Small Cell Lung Cancer Trial in Seoul (Osimertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 24, 2021

Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic sampling - AZD9291, Rifampicin, AZD9291 tablet dosing)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Pharmacokinetic sampling - AZD9291
  • +4 more
  • Atlanta, Georgia
  • +17 more
Jun 18, 2021

COPD, Non Small Cell Lung Cancer Trial in Seoul (Vilanterol and Umeclidinium Bromide, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Non Small Cell Lung Cancer
  • Vilanterol and Umeclidinium Bromide
  • Placebo
  • Seoul, Korea, Republic of
    Samsung Medical Center
Apr 1, 2021

Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • +2 more
  • Hefei, Anhui, China
  • +43 more
Feb 3, 2021